Abstract
Background: Previous studies have shown that haloperidol biotransformation is mainly metabolized by CYP2D6. The CYP2D6 gene is highly polymorphic, contributing to inter-individual differences in enzymatic activity, and may impact haloperidol biotransformation rates, resulting in variable drug efficacy and safety profiles.
Objective: The study aimed to investigate the correlation of the CYPD6 activity with haloperidol's efficacy and safety rates in patients with alcohol-induced psychotic disorders.
Methods: One hundred male patients received 5-10 mg/day haloperidol by injections for 5 days. The efficacy and safety assessments were performed using PANSS, UKU, and SAS-validated psychometric scales.
Results: No relationship between haloperidol efficacy or safety and the experimental endogenous pharmacometabolomic marker for CYP2D6 activity, urinary 6-НО-ТНВС/pinoline ratio was identified. In contrast, we found a statistically significant association between haloperidol adverse events and the most common CYP2D6 loss-of-function allele CYP2D6*4 (p<0.001).
Conclusion: Evaluation of the single polymorphism rs3892097 that defines CYP2D6*4 can predict the safety profile of haloperidol in patients with AIPD, whereas metabolic evaluation using an endogenous marker was not a suitable predictor. Furthermore, our results suggest haloperidol dose reductions could be considered in AIPD patients with at least one inactive CYP2D6 allele.
Keywords: CYP2D6, pharmacogenetics, personalized medicine, alcohol-induced psychotic disorder, alcoholic hallucinosis, haloperidol.
[PMID: 21206866]
[http://dx.doi.org/10.4103/0972-6748.119646] [PMID: 24250051]
[http://dx.doi.org/10.1007/s11011-013-9457-4] [PMID: 24307180]
[http://dx.doi.org/10.1080/15504263.2019.1619008] [PMID: 31161915]
[http://dx.doi.org/10.1177/070674378002500111] [PMID: 6102889]
[http://dx.doi.org/10.1080/10550490701375269] [PMID: 17612834]
[http://dx.doi.org/10.1007/s11011-011-9273-7] [PMID: 22147223]
[http://dx.doi.org/10.1002/14651858.CD009831.pub2] [PMID: 25592299]
[http://dx.doi.org/10.1073/pnas.97.14.7673] [PMID: 10884398]
[http://dx.doi.org/10.3389/fphar.2019.01045] [PMID: 31607910]
[http://dx.doi.org/10.2165/00003088-199937060-00001] [PMID: 10628896]
[http://dx.doi.org/10.1038/gim.2016.33] [PMID: 27101133]
[http://dx.doi.org/10.1124/dmd.108.023242] [PMID: 18784265]
[http://dx.doi.org/10.2133/dmpk.DMPK-14-RG-014] [PMID: 24647041]
[http://dx.doi.org/10.1002/cpt.690] [PMID: 28378927]
[http://dx.doi.org/10.1002/cpt.1643] [PMID: 31544239]
[http://dx.doi.org/10.1038/gim.2016.87] [PMID: 27441996]
[http://dx.doi.org/10.3390/genes11111295] [PMID: 33143137]
[http://dx.doi.org/10.1067/mcp.2002.127494] [PMID: 12386646]
[http://dx.doi.org/10.1124/dmd.108.025056] [PMID: 19095720]
[http://dx.doi.org/10.1177/02698811221112939] [PMID: 35861192]
[http://dx.doi.org/10.1093/schbul/13.2.261] [PMID: 3616518]
[http://dx.doi.org/10.1111/j.1600-0447.1987.tb10566.x] [PMID: 2887090]
[http://dx.doi.org/10.1111/j.1600-0447.1970.tb02066.x] [PMID: 4917967]
[http://dx.doi.org/10.1038/gim.2016.80] [PMID: 27388693]
[http://dx.doi.org/10.1111/bcp.14626] [PMID: 33118660]
[http://dx.doi.org/10.2147/PGPM.S110385] [PMID: 27695358]
[http://dx.doi.org/10.1038/s41431-019-0480-8] [PMID: 31358955]